The Peak Pharmaceuticals (PKPH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 66.67%, with a year-to-date return of 53.84%. In the past month, the stock has decreased 57.14%, reflecting recent market activity.
As of the latest close, Peak Pharmaceuticals traded at $1.50 with a market cap of $588,000.00 and volume of 1,917 shares. Five years ago, the stock traded at $0.01, representing a 11,011.11% increase over that period. At the time, it had a market cap of $1.18 million and a volume of 3,050 shares.